Skip to main content

Zimmer Biomet Holdings, Inc.'s Form 4 filing

ZimVie Inc. (ZIMV) · filed Feb 3, 2023

Accession no.
0001062993-23-002100
Filed
Feb 3, 2023
Trade date
Feb 1, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 1 non-derivative transaction. Open-market sales total $49.1M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Zimmer Biomet Holdings, Inc.CIK 000113686910% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 1, 2023Common StockSSaleDisposed−5,131,946$9.57F1−$49,112,723.220Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The reporting person exchanged 5,131,946 shares of the common stock of the Issuer for the cancellation of $49.1 million aggregate principal amount of indebtedness of the reporting person in a debt-for-equity exchange.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)